All In MedTech

Company

Alphatec Spine

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Alphatec Spine is on our public-company list (ticker ATEC). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

ATEC

Nasdaq · Alphatec Holdings, Inc.

Public float

$1.30B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$764M

Fiscal year ending Dec 31, 2025

Net income

-$143M

Fiscal year ending Dec 31, 2025

R&D spending

$76.3M

Fiscal year ending Dec 31, 2025

Cash

$79.9M

As of Sep 30, 2026

Long-term debt

$547M

As of Sep 30, 2026

Shares outstanding

155.1M

As of Oct 22, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2023–$213M––
2021$132M$132M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is free with an account

For Alphatec Spine we have 1 shareholder with 5% or more.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

The 8 newest of 71 since 2015.

Search the Clearance Tracker

70 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

1 more trials with a free account

Reports received

270

Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

Malfunction reports

214

79% of reports

Injury reports

54

20% of reports

Death reports

1

0.4% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 236400
Jan 247000
Feb 247400
Mar 2411200
Apr 2416300
May 248300
Jun 2413300
Jul 2413500
Aug 2410400
Sep 2411200
Oct 2417400
Nov 2411900
Dec 2412300
Jan 2513100
Feb 2514300
Mar 2516400
Apr 25241400
May 25181300
Jun 25281600
Jul 25201100
Aug 2514500
Sep 2513300
Oct 259500
Nov 2512200
Dec 2531600
Jan 267300
Feb 2616600
Mar 2621000
Apr 26171300
May 2624100
Jun 2619610
Jul 2624501
Aug 2613300
Sep 2621600
Oct 269300
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

56 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.